
Psilocybin (Magic Mushrooms) | National Institute on Drug Abuse
Jan 24, 2024 · Psilocin activity at the 5HT2a receptor affects how the brain works and how different brain regions communicate with each other. These altered patterns of brain activity …
Law enforcement seizures of psilocybin mushrooms rose …
Feb 6, 2024 · Law enforcement seizures of “magic mushrooms” or “shrooms” containing the psychoactive component psilocybin increased dramatically in the United States between …
La psilocibina (setas u hongos mágicos) - National Institute on …
Jan 24, 2024 · Cuando una persona toma psilocibina, su cuerpo la convierte en otra sustancia, la psilocina. La psilocina se une y activa los receptores, o sitios de unión, para la serotonina …
HALLUCINOGENS AND DISSOCIATIVE DRUGS Including LSD, Psilocybin, Peyote, DMT, Ayahuasca, PCP, Ketamine, Dextromethorphan, and Salvia
HALLUCINOGENS AND DISSOCIATIVE DRUGS Including LSD, PCP, Ketamine, Psilocybin, Salvia, Peyote, and Dextromethorphan
Psychedelic and Dissociative Drugs | National Institute on Drug …
Aug 29, 2024 · Psychedelic and dissociative drugs can temporarily alter a person’s mood, thoughts, and perceptions of reality. 1 Among other health effects and safety concerns, people …
Xylazine | National Institute on Drug Abuse (NIDA)
Jan 8, 2025 · Xylazine is a tranquilizer, pain reliever, and central nervous system depressant that is U.S. Food and Drug Administration (FDA)-approved for use in veterinary medicine.
NIDA IRP - Michael Baumann, Ph.D.
Background. Michael H. Baumann, PhD, is a Staff Scientist and Facility Head at the National Institute on Drug Abuse, Intramural Research Program, in Baltimore, MD. Dr. Baumann joined …
Psychedelic and Dissociative Drugs as Medicines
Jan 24, 2024 · Technology such as brain imaging expanded scientists’ capacity to study psychedelic and dissociative drugs in the laboratory, stimulating a new wave of research in the …
Demystifying Medicine - National Institute on Drug Abuse (NIDA)
Apr 23, 2024 · The Demystifying Medicine Series, jointly sponsored by FAES and NIH, includes presentations on pathology, diagnosis, and therapy in the context of major disease problems …